EDMONTON, Alberta, November 27, 2015 – BioNeutra Global Corporation (CSE: BGA) (“BioNeutra” or the “Company“) is pleased to announce that its wholly-owned subsidiary, BioNeutra North America Inc., and the defendant have jointly filed a dismissal of legal claims and counterclaims in the U.S. action1 and a discontinuance of legal claims and counterclaims in the Canadian action2.
BioNeutra continues to produce isomalto-oligosaccharide (IMO) using its patented processes and continues to sell it under the trademark VitaFiber™ to functional and health food manufacturers as well as retail customers in Canada, the U.S., Europe, the United Kingdom, Mexico, and other global markets.